Microsoft PowerPoint - L00 Introduction

834 / 1068

Endpoint STAR-01
ACCORD
12/0405
CAO/ARO/
AIO-04
NSABP
R-04
PETACC-6
PCR 16% both
arms
14% vs 19% 12.8% vs
16.5%
(p=0.038)
19% vs
21%
11.5% vs
13%
CRM 4% vs 7% 8% vs 13% 5% vs 6% No data 2% vs 2%
Oxaliplatin Phase III trials: Control arm in red